Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Blockade in Robot-Assisted Prostatectomy
NCT02109133Completed
- Sponsor
- Yonsei University
- Start
- May 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rocuronium in prostate cancer (PCa) (2 arms), sponsored by Yonsei University. Primary endpoint: Maximum Intraocular Pressure During RALRP Under Deep Neuromuscular Blockade. Started May 2014; status: completed.
02
Drugs
rocuronium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02109133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109133.